We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A Jacksonville, Florida-based compounding pharmacy has agreed to pay $8.4 million to settle allegations that it billed the U.S. government for improper pain prescriptions, in violation of the False Claims Act. Read More
Generics manufacturer Amphastar Pharmaceuticals was silenced by a federal judge in California over its latest whistleblower lawsuit in a 12-year battle over Sanofi’s blockbuster anticoagulant Lovenox. Read More
A Johnson & Johnson factory that closed in 2010 after being at the center of massive recalls of over-the-counter products is close to reopening, the company said Tuesday. Read More
AstraZeneca and Eli Lilly have agreed to conduct a clinical trial to assess the safety and preliminary efficacy of AZ’s experimental anti-PD-L1 immune checkpoint inhibitor MEDI4736 in combination with Lilly’s Cyramza treatment for patients with advanced solid cancer tumors. Read More